Todo DSpace

Listar por tema "radioisotope"

Mostrando ítems 1-7 de 7

    • Diagnosis and management of chronic coronary artery disease 

      Triposkiadis, F.; Starling, R. C.; Stefanadis, C. (2007)
      Coronary artery disease (CAD) usually coexists with atherosclerosis of other arterial trees and is accelerated by several risk factors. It may remain asymptomatic for a long period affecting the vessel wall with no lumen ...

    • EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging 

      Sciagrà R., Lubberink M., Hyafil F., Saraste A., Slart R.H.J.A., Agostini D., Nappi C., Georgoulias P., Bucerius J., Rischpler C., Verberne H.J., Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) (2021)
      The use of cardiac PET, and in particular of quantitative myocardial perfusion PET, has been growing during the last years, because scanners are becoming widely available and because several studies have convincingly ...

    • From courage to ischaemia: Is still there a role for myocardial perfusion imaging (MPI) in stable coronary artery disease? 

      Georgoulias P., Angelidis G., Tsougos I., Valotassiou V. (2022)
      [No abstract available]

    • Neuroimaging methods in epilepsy of temporal origin 

      Tsougos I., Kousi E., Georgoulias P., Kapsalaki E., Fountas K.N. (2019)
      Background: Temporal Lobe Epilepsy (TLE) comprises the most common form of symptomatic refractory focal epilepsy in adults. Accurate lateralization and localization of the epileptogenic focus are a significant prerequisite ...

    • Organs dosimetry in targeted radionuclide therapy 

      Alnaaimi M., Sulieman A., Alkhorayef M., Salah H., Alduaij M., Algaily M., Alomair O., Alashban Y., Almohammad H.I., Bradley D., Kappas C. (2021)
      The objective of this study is to assess the patients' effective and organ dose during theranostic applications in Kuwait. In total, eighteen adults' patients were conducted nuclear medicine procedures with 177Lu Dotatate ...

    • Prostate cancer: ESMO consensus conference guidelines 2012 

      Horwich, A.; Hugosson, J.; de reijke, T.; Wiegel, T.; Fizazi, K.; Kataja, V.; Parker, C.; Bellmunt, J.; Berthold, D.; Bill-axelson, A.; Carlsson, S.; Daugaard, G.; De meerleer, G.; De reijke, T.; Dearnaley, D.; Fonteyne, V.; Gillessen, S.; Heinrich, D.; Kwiatkowski, M.; Nilsson, S.; Padhani, A.; Papandreou, C.; Roobol, M.; Sella, A.; Valdagni, R.; Van der kwast, T.; Verhagen, P. (2013)
      The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological ...

    • Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA 

      Psimadas D., Valotassiou V., Alexiou S., Tsougos I., Georgoulias P. (2018)
      Molecular imaging and therapy is a rapidly evolving field in research and clinical medicine. The use of the exciting and attractive properties of radioisotopes for imaging and therapy has made Nuclear Medicine very significant ...